Applying Guideline-Based Treatment for Patients with Renal Cell Carcinoma

Applying Guideline-Based Treatment for Patients with Renal Cell Carcinoma

More than 76,000 people in the US are diagnosed each year with renal cell carcinoma (RCC). Increased approval of oral therapies and recent guideline updates both elevate the pharmacist’s important role to support patients in managing their treatment. Learn about pathophysiology, assessments, diagnosis, and treatment algorithm updates so you can appropriately manage patients with RCC.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. List the signs, symptoms, and diagnostic and staging criteria of renal cell carcinoma
2. Apply guideline-based treatment algorithms to persons with renal cell carcinoma
3. Develop monitoring plans for persons with renal cell carcinoma and medications used to treat renal cell carcinoma
4. Formulate evidence-based recommendations for persons with renal cell carcinoma
5. Discuss the role of the pharmacy team in the patient journey for persons with renal cell carcinoma 

Kelly Brunk, PharmD, BCOP
Clinical Pharmacist
The University of Kansas Health System

Kelly Brunk does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.

Note: Off-label use will be discussed in this course. 

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: October 1, 2021
Planned Expiration Date: October 1, 2024

Copyright 2021, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

Universal Activity Number (UAN): 0107-0000-21-305-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


1h 0m

Topic Designator

Disease State/Drug Therapy



ACPE Topic

01 Drug Therapy





Release Date






ACPE Number


This course is in our subscription.